APOBEC3B mRNA expression was found to be upregulated in most breast cancers and tumors expressing high levels of APOBEC3B had a 2-fold increase in mutations compared with tumors expressing low APOBEC3B levels. This evidence concerns the gene APOBEC3B and breast cancer.